Given the absence of clinical and laboratory evidence of hematological, rheumatological, and infectious diseases, and the presence of anti-GM-CSF antibodies in the patient serum and BALF, the diagnosis of aPAP was established. This evidence concerns the gene CSF2 and autoimmune pulmonary alveolar proteinosis.